Development of a universal chemiluminometric genotyping method for high-throughput detection of 7 LDLR gene mutations in greek population

Clinical Biochemistry

Volumn 41, Issue 4-5, 2008, Pages 335-342

  Glynou, Kyriaki ^a   Laios, Eleftheria ^b   Drogari, Euridiki ^b   Tsaoussis, Vassilis ^a  

^a Medicon SA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chemiluminometric genotyping; Familial hypercholesterolemia; LDLR; Mutation detection

Indexed keywords

ADENINE; CYTOSINE; DEOXYCYTIDINE TRIPHOSPHATE; DNA POLYMERASE; FLUORESCEIN; GUANINE; HORSERADISH PEROXIDASE; LOW DENSITY LIPOPROTEIN RECEPTOR; REAGENT; THYMINE;

ACCURACY; ALLELE; AMPLICON; ARTICLE; CHEMOLUMINESCENCE; CONJUGATION; FAMILIAL HYPERCHOLESTEROLEMIA; FREEZE DRYING; GENE; GENE MUTATION; GENE PROBE; GENOTYPE; GREECE; HIGH THROUGHPUT SCREENING; HUMAN; LDLR GENE; MAJOR CLINICAL STUDY; MICROTITER PLATE ASSAY; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROBE EXTENSION REACTION; SENSITIVITY AND SPECIFICITY; TECHNIQUE; VALIDITY;

CHEMILUMINESCENT MEASUREMENTS; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GREECE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, LDL; REPRODUCIBILITY OF RESULTS;

EID: 39149139632     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.12.016     Document Type: Article

References (38)

1. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th ed. (1995), McGraw Hill, New York 1981-2030
2. Villeger L., Abifadel M., Allard D., Rabes J.P., Thiart R., Kotze M.J., et al. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 20 (2002) 81-87
3. Mavroidis N., Traeger-Synodinos J., Kanavakis E., Drogari E., Matsaniotis N., Humphries S.E., et al. A high incidence of mutations in exon 6 of the low-density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation. Hum Mutat 9 (1997) 274-276
4. Traeger-Synodinos J., Mavroidis N., Kanavakis E., Drogari E., Humphries S.E., Day I.N.M., et al. Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands. Hum Genet 102 (1998) 343-347
5. Miltiadous G., Elisaf M., Xenophontos S., Manoli P., and Cariolou M.A. Segregation of a novel LDLR gene mutation (I430T) with familial hypercholesterolaemia in a Greek pedigree. Hum Mutat 16 (2000) 277
6. Xenophontos S.L., Pierides A., Demetriou K., Avraamides P., Manoli P., Ayton N., et al. Geographical clustering of low density lipoprotein receptor gene mutations (C292X; Q363X; D365E & C660X) in Cyprus. Hum Mutat 15 (2000) 380
7. Miltiadous G., Elisaf M., Bairaktari H., Xenophontos S.L., Manoli P., and Cariolou M.A. Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern Greece. Hum Mutat 17 (2001) 432-433
8. Dedoussis G.V., Pitsavos C., Kelberman D., Skoumas J., Prassa M.E., Choumerianou D.M., et al. FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia. Clin Genet 64 (2003) 414-419
9. Dedoussis G.V., Genschel J., Bochow B., Pitsavos C., Skoumas J., Prassa M., et al. Molecular characterization of familial hypercholesterolemia in German and Greek patients. Hum Mutat 23 (2004) 285-286
10. Dedoussis G.V., Skoumas J., Pitsavos C., et al. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations. Eur J Clin Invest 34 (2004) 402-409
11. Leonard J.V., Whitelaw A.G., Wolff O.H., Lloyd J.K., and Slack J. Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J 1 (1977) 1566-1568
12. Kwiterovich Jr. P.O., Fredrickson D.S., and Levy R.I. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest 53 (1974) 1237-1249
13. Kastelein J.J. Screening for familial hypercholesterolaemia. Effective, safe treatments and DNA testing make screening attractive [Editorial]. BMJ 321 7275 (2000) 1483-1484
14. Sudhof T.C., Goldstein J.L., Brown M.S., and Russell D.W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228 (1985) 815-822
15. Humphries S.E., Gudnason V., Whittall R., and Day I.N. Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. International Federation of Clinical Chemistry Scientific Division: Committee on Molecular Biology Techniques. Clin Chem 43 (1997) 427-435
16. Whittall R., Gudnason V., Weavind G.P., Day L.B., Humphries S.E., and Day I.N. Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene. J Med Genet 32 (1995) 509-515
17. Reshef A., Nissen H., Triger L., Hensen T.S., Eliav O., Schurr D., et al. Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet 98 (1996) 581-586
18. Day I.N., Whittall R.A., O'Dell S.D., et al. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 10 (1997) 116-127
19. Nissen H., Guldberg P., Hansen A.B., Petersen N.E., and Horder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 8 (1996) 168-177
20. Ekstrom U., Abrahamson M., Sveger T., Lombardi P., and Nilsson-Ehle P. An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia. Hum Genet 96 (1995) 147-150
21. Bodamer O.A., Bercovich D., Schlabach M., Ballantyne C., Zoch D., and Beaudet A.L. Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem 48 (2002) 1913-1918
22. Naoumova R.P., Neuwirth C., Pottinger B., Whittal R., Humphries S.E., and Soutar A.K. Genetic diagnosis of familial hypercholesterolaemia: a mutation and a rare non-pathogenic amino acid variant in the same family. Atherosclerosis 174 (2004) 67-71
23. Liguori R., Argiriou A., and Simone V.D. A rapid method for detecting mutations of the human LDL receptor gene by complete cDNA sequencing. Mol Cell Probes 17 (2003) 15-20
24. Sozen M., Whittall R., and Humphries S.E. Mutation detection in patients with familial hypercholesterolaemia using heteroduplex and single strand conformation polymorphism analysis by capillary electrophoresis. Atheroscler Suppl 5 (2004) 7-11
25. Alharbi K.K., Aldahmesh M.A., Spanakis E., Haddad L., Whittall R.A., Chen X.H., et al. Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population. Genome Res 15 (2005) 967-977
26. Heath K.E., Humphries S.E., Middleton-Price H., and Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 9 (2001) 244-252
27. Fouchier S.W., Defesche J.C., Umans-Eckenhausen M.W., and Kastelein J.P. The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 109 (2001) 602-615
28. Umans-Eckenhausen M.A., Defesche J.C., Sijbrands E.J., Scheerder R.L., and Kastelein J.J. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357 9251 (2001) 165-168
29. Umans-Eckenhausen M.A., Sijbrands E.J., Kastelein J.J., and Defesche J.C. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 106 (2002) 3031-3036
30. Fouchier S.W., Kastelein J.P., and Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in the Netherlands. Hum Mutat 26 (2005) 550-556
31. Tejedor D., Castillo S., Mozas P., Jimenez E., Lopez M., Tejedor M.T., et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51 (2005) 1137-1144
32. Leitersdorf E., Tobin E.J., Davignon J., and Hobbs H.H. Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85 (1990) 1014-1023
33. Kotze M.J., Langenhoven E., Warnich L., du Plessis L., and Retief A.E. The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann Hum Genet 55 (1991) 115-121
34. Laios E., and Drogari E. Analysis of LDLR mutations in familial hypercholesterolemia patients in Greece by use of the NanoChip microelectronic array technology. Clin Chim Acta 374 (2006) 93-99
35. Glynou K., Kastanis P., Boukouvala S., Tsaoussis V., Ioannou P.C., Christopoulos T.K., et al. High-throughput microtiter well-based chemiluminometric genotyping of 15 HBB gene mutations in a dry-reagent format. Clin Chem 53 (2007) 384-391
36. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 3 (1988) 1215
37. Laios E., and Glynou K. Allelic drop-out in the LDLR gene affects mutation detection in familial hypercholesterolemia. Clin Biochem 41 (2008) 38-40
38. Syvanen A. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Genet Rev 2 (2001) 930-942